NCT06118021View on ClinicalTrials.gov

A Study of HS-20094 Evaluating Weight Loss in Obese and Overweight Chinese Subjects

PHASE2RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 16, 2023

Primary Completion Date

August 30, 2024

Study Completion Date

October 16, 2024

Conditions
Overweight and Obesity
Interventions
DRUG

HS-20094

Administered SC

DRUG

Placebo

Administered SC

Trial Locations (2)

100044

RECRUITING

the Fourth Affiliated Hospital of Harbin Medical University, Harbin

150001

RECRUITING

The Fourth Affiliated Hospital of Harbin Medical University, Harbin

Sponsors
All Listed Sponsors
lead

Jiangsu Hansoh Pharmaceutical Co., Ltd.

INDUSTRY